Wyeth was bought by Pfizer for $68 billion in 2009. Pfizer also just bought King Pharmaceutical for $3.6 billion this year. They are the largest biopharma in this country and make acquisitions several times per decade. Whenever these mergers occur in biopharma, they follow the Welsh principle and support only the top 6 R&D projects. But Pfizer was targeting specific drugs, not biological. Contrary to what the first "guy" to respond to your post implied . . . Pfizer was not going after vaccines or biological that would be owned by a third party like Inovio. Remember making the antigen into a ringed compound is novel art which is patented on a case by case basis by Inovio.
Too bad s________k unzipped his fly and looked in astonishment that he did not have one. For lying p_____, it is in their mouth!?!